HSBC Holdings
RLAY icon

HSBC Holdings’s Relay Therapeutics RLAY Stock Holding History

HSBC Holdings’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-98,290
Closed -$504K – 3124
2025
Q3 		$504K Sell
98,290
-5,967
-6% -$22.8K ﹤0.01% 2097
2025
Q2 		$352K Sell
104,257
-12,151
-10% -$36.1K ﹤0.01% 2346
2025
Q1 		$300K Buy
116,408
+4,639
+4% +$18.2K ﹤0.01% 2375
2024
Q4 		$458K Buy
111,769
+77,349
+225% +$421K ﹤0.01% 2236
2024
Q3 		$247K Sell
34,420
-6,919
-17% -$51.7K ﹤0.01% 2477
2024
Q2 		$257K Buy
41,339
+22,400
+118% +$153K ﹤0.01% 2394
2024
Q1 		$157K Sell
18,939
-581
-3% -$5.67K ﹤0.01% 2746
2023
Q4 		$218K Buy
19,520
+4,503
+30% +$38K ﹤0.01% 2432
2023
Q3 		$126K Buy
15,017
+2,857
+23% +$30.7K ﹤0.01% 2519
2023
Q2 		$153K Buy
12,160
+1,607
+15% +$20K ﹤0.01% 2377
2023
Q1 		$175K Sell
10,553
-1,576
-13% -$28.3K ﹤0.01% 2417
2022
Q4 		$175K Buy
+12,129
New +$232K ﹤0.01% 2802

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's RLAY Position: Q4 2025 in Review

HSBC Holdings sold out of Relay Therapeutics (RLAY) in Q4 2025, closing a stake of 98,290 shares — an estimated $504K sold.

HSBC Holdings first reported a position in RLAY in Q4 2022 and held it in 12 quarters. The position peaked at $504K in Q3 2025. 226 funds tracked by Wall St. Rank hold RLAY as of Q4 2025.

  • HSBC Holdings reported no remaining Relay Therapeutics position as of Q4 2025 after selling out during the quarter.
  • HSBC Holdings sold 98,290 Relay Therapeutics shares in Q4 2025, an estimated $504K.
  • HSBC Holdings first reported a position in Relay Therapeutics in Q4 2022 and held it in 12 quarters.
  • HSBC Holdings's Relay Therapeutics position peaked at $504K in Q3 2025.
  • 226 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.